Cost of Revenue

Total Cost of Revenue

Pfizer Total Cost of Revenue decreased by 32.7% to $3.55B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 24.7%, from $2.85B to $3.55B. Over 4 years (FY 2021 to FY 2025), Total Cost of Revenue shows a downward trend with a -15.0% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.

Analysis

StatementIncome Statement
SectionCost of Revenue
CategoryEfficiency
SignalLower is better
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026

How to read this metric

An increase relative to revenue may indicate rising component costs or manufacturing inefficiencies, whereas a decrease suggests better economies of scale.

Detailed definition

The direct costs attributable to the production of the goods sold and the delivery of services. This typically encompass...

Peer comparison

In the consumer electronics industry, this is often compared against revenue to determine the efficiency of the supply chain.

Metric ID: is_total_cost_of_revenue

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$7.05B$9.97B$9.59B$9.98B$8.65B$6.06B$9.65B$4.89B$3.24B$9.27B$7.56B$3.38B$3.30B$5.26B$5.91B$2.85B$3.78B$4.17B$5.27B$3.55B
QoQ Change+41.5%-3.9%+4.1%-13.4%-29.9%+59.1%-49.4%-33.7%+186.3%-18.4%-55.3%-2.3%+59.5%+12.3%-51.9%+32.8%+10.4%+26.4%-32.7%
YoY Change+22.7%-39.2%+0.6%-51.1%-62.6%+52.9%-21.6%-30.8%+1.9%-43.2%-21.9%-15.8%+14.5%-20.7%-10.8%+24.7%
Range$2.85B$9.98B
CAGR-13.5%
Avg YoY Growth-12.5%
Median YoY Growth-18.3%

Business Segments

View all
SegmentQ1 '26
Biopharma$3.03B
Total$3.55B

Frequently Asked Questions

What is Pfizer's total cost of revenue?
Pfizer (PFE) reported total cost of revenue of $3.55B in Q1 2026.
How has Pfizer's total cost of revenue changed year-over-year?
Pfizer's total cost of revenue increased by 24.7% year-over-year, from $2.85B to $3.55B.
What is the long-term trend for Pfizer's total cost of revenue?
Over 4 years (2021 to 2025), Pfizer's total cost of revenue has grown at a -15.0% compound annual growth rate (CAGR), from $30.82B to $16.07B.
What does total cost of revenue mean?
The direct cost of making the products or providing the services that a company sells.